Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Biotech
Lilly inks deals to buy 3 vaccine developers for up to $3.8B
Lilly is acquiring Curevo, LimmaTech and Vaccine Company to extend its shopping spree into viral and bacterial pathogen R&D.
Nick Paul Taylor
May 26, 2026 7:57am
Valneva to lay off up to 15%, faces tough travel vaccine market
May 13, 2026 8:35am
New antibodies stop measles from stabbing cells, study finds
May 7, 2026 11:00am
Fierce Pharma
Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad
Mar 3, 2026 4:58pm
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am
Jay Bhattacharya faces Senate grilling on NIH disruptions
Feb 3, 2026 5:20pm
